Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

The agouti gene may help understand and treat obesity.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Combining stem cells with ATP significantly boosts hair regrowth in mice with hair loss.

Higher PHGDH levels cause unusual melanin buildup in hair follicles.

Genetic marker rs12558842 strongly linked to male hair loss.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

The mutation causing Hutchinson-Gilford progeria syndrome leads to severe skin problems and early death in mice.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

Platelet rich plasma therapy significantly improves hair growth and increases the number of hair follicles in men with androgenetic alopecia.

Young adults with hair loss face higher risk of stiff arteries.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Combining microneedling with glycosaminoglycan lotion may improve hair growth in mild androgenetic alopecia.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

GLP-1RA therapy may increase the risk of hair loss.

The document concludes that measuring γ-glutamyl transpeptidase activity is more accurate with a higher substrate concentration and using diluted acetic acid to stop the reaction.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Personalized multimodal treatment significantly improved hair growth and scalp coverage in androgenetic alopecia without side effects.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

PRP can help hair growth in some types of hair loss.

PRP therapy is promising for hair loss but needs standardized methods and personalization.

PRP injections significantly increased hair count and density with less pain.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.